These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 39029425)

  • 1. BALAD score predicts the recurrence and survival in the patients who underwent initial hepatectomy for HCC.
    Nakagawa S; Hayashi H; Itoyama R; Kitano Y; Mima K; Okabe H; Baba H
    Surg Oncol; 2024 Aug; 55():102097. PubMed ID: 39029425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model combining pre-transplant tumor biomarkers and tumor size shows more utility in predicting hepatocellular carcinoma recurrence and survival than the BALAD models.
    Wongjarupong N; Negron-Ocasio GM; Chaiteerakij R; Addissie BD; Mohamed EA; Mara KC; Harmsen WS; Theobald JP; Peters BE; Balsanek JG; Ward MM; Giama NH; Venkatesh SK; Harnois DM; Charlton MR; Yamada H; Algeciras-Schimnich A; Snyder MR; Therneau TM; Roberts LR
    World J Gastroenterol; 2018 Mar; 24(12):1321-1331. PubMed ID: 29599607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applicability of BALAD score in prognostication of hepatitis B-related hepatocellular carcinoma.
    Chan SL; Mo F; Johnson P; Li L; Tang N; Loong H; Chan AW; Koh J; Chan AT; Yeo W
    J Gastroenterol Hepatol; 2015 Oct; 30(10):1529-35. PubMed ID: 25968302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
    Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
    World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
    Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
    World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is serum alpha-fetoprotein useful for predicting recurrence and mortality specific to hepatocellular carcinoma after hepatectomy? A test based on propensity scores and competing risks analysis.
    Shim JH; Yoon DL; Han S; Lee YJ; Lee SG; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS
    Ann Surg Oncol; 2012 Nov; 19(12):3687-96. PubMed ID: 22644512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Significance of Preoperative Hepatocellular Carcinoma With High
    Yamao T; Yamashita YI; Imai K; Umezaki N; Tsukamoto M; Kitano Y; Arima K; Miyata T; Nakagawa S; Okabe H; Hayashi H; Chikamoto A; Ishiko T; Baba H
    Anticancer Res; 2019 Feb; 39(2):883-889. PubMed ID: 30711971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

  • 9. Fucosylated fraction of alpha-fetoprotein as a predictor of prognosis in patients with hepatocellular carcinoma after curative treatment.
    Tamura Y; Igarashi M; Suda T; Wakai T; Shirai Y; Umemura T; Tanaka E; Kakizaki S; Takagi H; Hiasa Y; Onji M; Aoyagi Y
    Dig Dis Sci; 2010 Jul; 55(7):2095-101. PubMed ID: 19731025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.
    Gan W; Huang JL; Zhang MX; Fu YP; Yi Y; Jing CY; Fan J; Zhou J; Qiu SJ
    J Surg Oncol; 2018 Jun; 117(7):1540-1547. PubMed ID: 29572833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological risk factors for recurrence within one year after initial hepatectomy for hepatocellular carcinoma.
    Hayashi M; Shimizu T; Hirokawa F; Inoue Y; Komeda K; Asakuma M; Miyamoto Y; Takeshita A; Shibayama Y; Tanigawa N
    Am Surg; 2011 May; 77(5):572-8. PubMed ID: 21679590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative α-fetoprotein response predicts tumor recurrence and survival after hepatectomy for hepatocellular carcinoma: A propensity score matching analysis.
    Li XL; Zhu XD; Cai H; Li Y; Zhou J; Fan J; Tang ZY; Sun HC
    Surgery; 2019 Jun; 165(6):1161-1167. PubMed ID: 30846192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PIVKA-II combined with tumor burden score to predict long-term outcomes of AFP-negative hepatocellular carcinoma patients after liver resection.
    Qiu ZC; Wu YW; Qi WL; Li C
    Cancer Med; 2024 Jan; 13(1):e6835. PubMed ID: 38130028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy.
    Ma WJ; Wang HY; Teng LS
    World J Surg Oncol; 2013 Aug; 11():212. PubMed ID: 23981851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Prognostic Value of Alpha-Fetoprotein Ratio in Patients With Resectable Alpha-Fetoprotein-Negative Hepatocellular Carcinoma.
    Sun LY; Cen WJ; Zeng XX; Zhong YY; Deng L; Yang JJ; Li M; Wang F
    Am Surg; 2024 Jun; 90(6):1240-1249. PubMed ID: 38214585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the risk factors for early death due to disease recurrence or progression within 1 year after hepatectomy in patients with hepatocellular carcinoma.
    Kamiyama T; Nakanishi K; Yokoo H; Kamachi H; Tahara M; Kakisaka T; Tsuruga Y; Todo S; Taketomi A
    World J Surg Oncol; 2012 Jun; 10():107. PubMed ID: 22697061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor marker levels before and after curative treatment of hepatocellular carcinoma as predictors of patient survival.
    Nanashima A; Taura N; Abo T; Ichikawa T; Sakamoto I; Nagayasu T; Nakao K
    Dig Dis Sci; 2011 Oct; 56(10):3086-100. PubMed ID: 21706206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential predictive factors for microvascular invasion in hepatocellular carcinoma classified within the Milan criteria.
    Imura S; Teraoku H; Yoshikawa M; Ishikawa D; Yamada S; Saito Y; Iwahashi S; Ikemoto T; Morine Y; Shimada M
    Int J Clin Oncol; 2018 Feb; 23(1):98-103. PubMed ID: 28875240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognoses, outcomes, and clinicopathological characteristics of very elderly patients with hepatocellular carcinoma who underwent hepatectomy.
    Shimada S; Kamiyama T; Orimo T; Nagatsu A; Asahi Y; Sakamoto Y; Kamachi H; Taketomi A
    World J Surg Oncol; 2020 Jun; 18(1):122. PubMed ID: 32522259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in highly sensitive alpha-fetoprotein for the prediction of the outcome in patients with hepatocellular carcinoma after hepatectomy.
    Toyoda H; Kumada T; Tada T; Ito T; Maeda A; Kaneoka Y; Kagebayashi C; Satomura S
    Cancer Med; 2014 Jun; 3(3):643-51. PubMed ID: 24591342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.